IPO registrations (S-1, F-1) · Registrants

INVIVO THERAPEUTICS HOLDINGS CORP.

SEC CIK
1292519 · filings on EDGAR ↗
Former names
Design Source, Inc. (2004–2010)
Registration
Form S-1, first filed 2011-02-01, last 2022-11-09; 8 initial registrations, 9 amendments
Outcome
Final prospectus filed 2018-06-22; declared effective 2011-07-29
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
NV
Business address
ONE KENDALL SQUARE, BUILDING 1400 EAST 4TH FLOOR, Cambridge, MA 02139
EDGAR entity type
operating
Insiders and CEO pay
INVIVO THERAPEUTICS HOLDINGS CORP. on the corporate pages

Offering terms

Final price
$2.00 per share (424B4 filed 2018-06-22)
Shares sold
388,403
Gross proceeds
$776,806 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol NVIV
Lead underwriters
Ladenburg Thalmann
Syndicate
Series A Warrant; Warrant and

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 39

FiledFormWhat it isName as filedEDGAR
2011-02-01S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-020271 ↗
2011-05-19S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-145252 ↗
2011-06-09S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-161974 ↗
2011-06-30S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-178842 ↗
2011-07-19S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-190971 ↗
2011-07-29EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-11-002328 ↗
2011-12-16S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001193125-11-344083 ↗
2012-01-19EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-12-000228 ↗
2012-04-23EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-12-001127 ↗
2013-05-22EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-13-001617 ↗
2015-02-10EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-15-000367 ↗
2016-06-17EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-16-004943 ↗
2016-06-17EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-16-004944 ↗
2016-06-17EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-16-004945 ↗
2018-01-29S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-004326 ↗
2018-02-09S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-008065 ↗
2018-02-12EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-18-000415 ↗
2018-04-24S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-026229 ↗
2018-06-14S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-040189 ↗
2018-06-20S-1MEFS-1MEF (added securities)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-041380 ↗
2018-06-20EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-18-001553 ↗
2018-06-22424B4424B4 (final prospectus)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-041756 ↗
2018-06-26424B4424B4 (final prospectus)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-18-042287 ↗
2019-05-28EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-19-001218 ↗
2019-06-28EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-19-001468 ↗
2019-11-14EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-19-002574 ↗
2020-02-21S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001047469-20-000997 ↗
2020-03-02S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001047469-20-001151 ↗
2020-03-05S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001047469-20-001217 ↗
2020-03-06EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-20-000479 ↗
2020-03-09424B4424B4 (final prospectus)INVIVO THERAPEUTICS HOLDINGS CORP.0001047469-20-001325 ↗
2020-05-22S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001047469-20-003187 ↗
2020-06-04EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-20-001343 ↗
2020-10-07S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-20-112754 ↗
2020-10-16S-1/AS-1/A (amendment)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-20-115633 ↗
2020-10-22EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-20-002952 ↗
2020-10-26424B4424B4 (final prospectus)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-20-117863 ↗
2022-11-09S-1S-1 (registration)INVIVO THERAPEUTICS HOLDINGS CORP.0001104659-22-116043 ↗
2022-11-21EFFECTEFFECT (declared effective)INVIVO THERAPEUTICS HOLDINGS CORP.9999999995-22-003362 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2018-06-14S-1/Aregistration statement1,486,486-Nasdaq NVIV3primary document; shares headline, cover names 3document ↗
2018-06-22424B4final prospectus$2.00388,403$776,806Nasdaq NVIV3primary document; price sentence, shares headline, proceeds computed, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Coker Peter LDirector,OfficerSecretary12006
Reichard Peter ADirector,OfficerPresident, CEO12006
Coker Peter L.Director,Officer,TenPercentOwnerSecretary12009
Reichard PeterDirector,Officer,TenPercentOwnerChief Executive Officer22009
LANGER ROBERTTenPercentOwner162010–2013
NOLEN GEORGEDirector42010–2013
PEDRA CHRISTIDirector32010–2011
REYNOLDS FRANCISDirector,Officer,TenPercentOwner; TenPercentOwnerCEO, CFO; Chief Executive Officer1472010–2014
ROBERTS RICHARD JOHNDirector172010–2022
KIMBERLIN KEVINTenPercentOwner22010
STERN ADAM KDirector52010–2012person page Fuzzy
Wirth EdwardOfficerChief Science Officer22011
HESS BRIANOfficerCHIEF SCIENCE OFFICER; Chief Technology Officer32012–2013
DiPietro KennethDirector82012–2018
MCCARTHY JOHN A JRDirector62013–2015
ASTRUE MICHAEL JOfficerInterim CEO; INTERIM CEO22013–2014
Moran Sean F.OfficerActing Chief Financial Officer42013
PERRY GREGORY DOfficerInterim CFO22013–2014
MCALLISTER STEVEN FOfficerChief Financial Officer; INTERIM CFO52014–2016
PERRIN MARK DDirector,OfficerCHIEF EXECUTIVE OFFICER62014–2017
JOSEPH TAMARA LOfficerSVP, General Counsel72014–2017
Ulich Thomas ROfficerChief Scientific Officer62014–2017
MARSHAK DANIEL RDirector82014–2022
MERRIFIELD C ANNDirector102014–2022
Lorianne Masuoka K.OfficerChief Medical Officer42015–2016
Morrison ChristinaDirector62016–2022
STAHL PAMELA JOfficerChief Commercial Officer32016–2017
Hatfield Jeffrey S.Director32016–2018
Golarz MelanieOfficerInterim CFO12017
McNulty ChristopherOfficerChief Financial Officer22017
Toselli Richard M.Director,Officer; OfficerCEO and CMO; Chief Medical Officer; See Remarks192017–2022person page Fuzzy
Modestino JeffreyOfficerSee Remarks12018
CHRISTOPHER RICHARDOfficerCFO and Treasurer; Chief Financial Officer62019–2022
ROSENTHAL BOBDirector32021–2022
Hamel HeatherOfficerChief Legal Officer and GC22022
Foose BriceTenPercentOwner32023–2024

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2022-10-14INVIVO THERAPEUTICS HOLDINGS CORP.Biotechnology$6,249,999$6,249,99911
2020-04-28INVIVO THERAPEUTICS HOLDINGS CORP.Biotechnology$3,022,576$3,022,57681

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerINVIVO THERAPEUTICS HOLDINGS CORP.MAForm D private offeringsCIK (EXACT)
SEC filerINVIVO THERAPEUTICS HOLDINGS CORP.SEC filers (EDGAR)CIK (EXACT)
Person pageAdam K SternPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageRichard M Toselli MdPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, MA first:

More with this interest.

In other datasets, the same topic (Technology) in MA:

Interests: Surgical & Medical Instruments & Apparatus · Technology